Luxmanan Selvanesan

ORCID: 0000-0001-8382-0722
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Nonmelanoma Skin Cancer Studies
  • Immunotherapy and Immune Responses
  • biodegradable polymer synthesis and properties
  • Single-cell and spatial transcriptomics
  • Electrospun Nanofibers in Biomedical Applications
  • Physiological and biochemical adaptations
  • Genomics and Chromatin Dynamics
  • Advanced biosensing and bioanalysis techniques
  • Calcium Carbonate Crystallization and Inhibition
  • Tissue Engineering and Regenerative Medicine
  • Polar Research and Ecology
  • Microbial Metabolites in Food Biotechnology
  • Acute Myeloid Leukemia Research
  • Plant nutrient uptake and metabolism
  • Enzyme Production and Characterization

University of Otago
2008-2021

Significance Triple-negative breast cancer (TNBC) is the most aggressive subtype. Despite extensive genome-sequencing efforts, there still an incomplete understanding of genetic networks driving TNBC. Here, we used Sleeping Beauty transposon mutagenesis to identify genes that cooperate with mutant P ten in induction We identified 12 candidate TNBC trunk drivers and a larger number progression genes. Subsequent functional validation studies eight human tumor suppressor genes, including...

10.1073/pnas.1613859113 article EN Proceedings of the National Academy of Sciences 2016-11-14

The systematic identification of genetic events driving cellular transformation and tumor progression in the absence a highly recurrent oncogenic driver mutation is challenge cutaneous oncology. In squamous cell carcinoma (cuSCC), high UV-induced mutational burden poses hurdle to achieve complete molecular landscape this disease. Here, we utilized Sleeping Beauty transposon mutagenesis system statistically define drivers keratinocyte cuSCC vivo UV-IR, identified both known suppressor genes...

10.1371/journal.pgen.1009094 article EN cc-by PLoS Genetics 2021-08-16

Abstract The systematic identification of genetic events driving cellular transformation and tumor progression in the absence a highly recurrent oncogenic driver mutation is challenge cutaneous oncology. In squamous cell carcinoma (cuSCC), high UV-induced mutational burden poses hurdle to achieve complete molecular landscape this disease. Here, we utilized Sleeping Beauty transposon mutagenesis system statistically define drivers keratinocyte cuSCC vivo UV-IR, identified both known...

10.1101/2019.12.24.887968 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2019-12-26
Coming Soon ...